09/01/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 9/1/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the MobileDetect Bio BCC19 Test Kit. The MobileDetect Bio BCC19 Test Kit is authorized for use with certain respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider. (PDF)
.png)
No hay comentarios:
Publicar un comentario